DCF conflict unresolvable: P50=$51 vs current $86 means the model says the stock is overvalued even in median scenario. P(above current)=0% with 18.8% implied growth vs actual 4-5% organic growth. RF model at 39.2% disagrees. Downgrading to 6 — will hold with existing stop but no add, and swap candidate if better opportunity emerges.
Steady 4.7% core growth, 23.2% op margin, $1.077B FCF, 61% recurring revenue. Target $85 vs current $90.25 — slightly above target. Strong quality but entry is above fair value estimate. Would be conviction 8 below $85. Missing: current price above entry target.
Fair Value Distribution — percentile bands
0.0% of simulations place fair value above current price
WHAT IS PRICED IN
Revenue-Based Reverse DCF
18.8%/yr
±5.0% · revenue growth to justify current price
FCF-Based Reverse DCF
14.3%/yr
±2.9% · FCF growth to justify current price
THE GAP
Market pricing margin expansion or capex normalization
KEY VALUE DRIVERS
Spearman correlation — what moves this valuation most
Non-discretionary spend = recession resistant; regulatory standards only tightening; post-Danaher spin premium.
Slower organic growth; acquisition integration; macro capex freeze delays projects.
Industrial capex freeze delays water infrastructure; acquisition proves dilutive.
Updated Mar 30
FY2025 revenue .5B (+6.0% GAAP, +4.7% core). Operating margins flat at 23.2%. Recurring revenue 61%. WQ segment +5.9% sales, +100bps margin. PQI +6.2% sales, -50bps margin. Strong cash generation .077...